Acadian Asset Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.8M Sell
820,070
-87,026
-10% -$271K ﹤0.01% 980
2026
Q1
$2.06M Buy
907,096
+183,748
+25% +$423K ﹤0.01% 952
2025
Q4
$2.02M Buy
723,348
+481,457
+199% +$1.72M ﹤0.01% 908
2025
Q3
$1.16M Sell
241,891
-113,635
-32% -$723K ﹤0.01% 1022
2025
Q2
$3.23M Buy
355,526
+345,235
+3,355% +$2.54M 0.01% 701
2025
Q1
$91K Buy
+10,291
New +$109K ﹤0.01% 1365
2024
Q1
Sell
-13,849
Closed -$266K 1728
2023
Q4
$266K Sell
13,849
-26,403
-66% -$478K ﹤0.01% 1176
2023
Q3
$650K Hold
40,252
﹤0.01% 947
2023
Q2
$766K Hold
40,252
﹤0.01% 950
2023
Q1
$585K Hold
40,252
﹤0.01% 1010
2022
Q4
$786K Hold
40,252
﹤0.01% 903
2022
Q3
$970K Hold
40,252
0.01% 811
2022
Q2
$1.27M Sell
40,252
-106,335
-73% -$3.85M 0.01% 761
2022
Q1
$6.45M Sell
146,587
-53,265
-27% -$2.29M 0.03% 407
2021
Q4
$8.69M Sell
199,852
-39,426
-16% -$1.55M 0.03% 335
2021
Q3
$7.48M Sell
239,278
-165,628
-41% -$6.52M 0.03% 366
2021
Q2
$17.1M Sell
404,906
-748,815
-65% -$29.1M 0.06% 240
2021
Q1
$43.4M Buy
1,153,721
+113,256
+11% +$3.54M 0.17% 131
2020
Q4
$28.1M Buy
1,040,465
+233,834
+29% +$6.01M 0.11% 166
2020
Q3
$20.3M Sell
806,631
-57,777
-7% -$843K 0.08% 205
2020
Q2
$6.59M Buy
864,408
+344,733
+66% +$2.52M 0.03% 422
2020
Q1
$4.75M Buy
519,675
+35,126
+7% +$212K 0.03% 404
2019
Q4
$2.5M Buy
484,549
+153,090
+46% +$983K 0.01% 618
2019
Q3
$1.93M Buy
331,459
+56,277
+20% +$252K 0.01% 689
2019
Q2
$881K Buy
275,182
+47,170
+21% +$161K ﹤0.01% 835
2019
Q1
$935K Buy
228,012
+151,886
+200% +$961K ﹤0.01% 913
2018
Q4
$482K Buy
+76,126
New +$790K ﹤0.01% 915
2018
Q1
Sell
-212,852
Closed -$4.02M 1790
2017
Q4
$4.02M Sell
212,852
-338,912
-61% -$7.51M 0.02% 407
2017
Q3
$16.1M Sell
551,764
-538,205
-49% -$15.9M 0.07% 222
2017
Q2
$35.1M Sell
1,089,969
-1,103,141
-50% -$36.2M 0.16% 140
2017
Q1
$75.9M Sell
2,193,110
-11,728
-0.5% -$419K 0.35% 77
2016
Q4
$77.8M Sell
2,204,838
-82,317
-4% -$2.78M 0.38% 74
2016
Q3
$79.4M Sell
2,287,155
-19,733
-0.9% -$691K 0.39% 75
2016
Q2
$86.2M Buy
2,306,888
+33,087
+1% +$1.24M 0.44% 70
2016
Q1
$91.9M Buy
2,273,801
+527,373
+30% +$19.6M 0.46% 66
2015
Q4
$62.8M Buy
1,746,428
+1,429,860
+452% +$51.7M 0.33% 82
2015
Q3
$10.1M Sell
316,568
-350,259
-53% -$11.9M 0.06% 286
2015
Q2
$22.7M Sell
666,827
-201,440
-23% -$6.79M 0.11% 191
2015
Q1
$29.4M Sell
868,267
-29,148
-3% -$1.02M 0.14% 168
2014
Q4
$31.5M Sell
897,415
-506,712
-36% -$17.1M 0.14% 162
2014
Q3
$46M Sell
1,404,127
-368,005
-21% -$12.5M 0.22% 134
2014
Q2
$60.2M Buy
1,772,132
+153,313
+9% +$5.25M 0.29% 91
2014
Q1
$56.7M Buy
1,618,819
+417,521
+35% +$14.7M 0.3% 82
2013
Q4
$43.9M Buy
1,201,298
+740,629
+161% +$27.2M 0.24% 104
2013
Q3
$15.9M Buy
460,669
+415,487
+920% +$14.5M 0.1% 179
2013
Q2
$1.53M Buy
+45,182
New +$1.5M 0.01% 423

Other funds holding ACH

Acadian Asset Management's ACH Position: Q2 2026 in Review

Acadian Asset Management reduced its Accendra Health (ACH) stake by 9.6% in Q2 2026, selling an estimated $271K and leaving 820,070 shares worth $2.8M. The position accounts for ﹤0.01% of the portfolio, ranked #980.

Acadian Asset Management first reported a position in ACH in Q2 2013 and has held it in 46 quarters since. The position peaked at $91.9M in Q1 2016. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Acadian Asset Management held 820,070 shares of Accendra Health worth $2.8M as of Q2 2026.
  • Acadian Asset Management sold 87,026 Accendra Health shares in Q2 2026, an estimated $271K.
  • Accendra Health made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #980 holding.
  • Acadian Asset Management first reported a position in Accendra Health in Q2 2013 and has held it in 46 quarters since.
  • Acadian Asset Management's Accendra Health position peaked at $91.9M in Q1 2016.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.